Loss of Atg16l1 did not impact basal growth of AKPS organoids in vitro (Supplementary Fig. 4c), suggesting that tumor-intrinsic loss of Atg16l1 may elicit tumor-extrinsic mechanisms of disease control in vivo. Here, ATG16L1 is linked to neoplasm.